基于妇科肿瘤耐药治疗中工程化外泌体的应用研究进展.

Gynecological malignant tumor is a serious threat to women′s health, with high morbidity and mortality among various female diseases. The key reason lies in the inadequate curative effect of traditional chemotherapy on relapsed and drug-resistant patients. In recent years, to explore the mechanism of chemotherapy resistance of tumor cells and to develop new chemotherapy reversal agents has become a focus of gynecological cancer researchers. Exosomes are a kind of multivesicular bodies originated from the formation of intracellular lysosomal particle invaginations, with biological properties such as low immunogenicity, innate targeting and acquired targeting, and high delivery efficiency. Therefore, exosomes can be used as an ideal, natural nanocarriers for drug delivery, which can not only reduce tumor resistance to chemotherapy drugs, improving the therapeutic effect of drugs, but also reduce the toxic and side effects of chemotherapy drugs on the whole body. This review summarizes the research progress of exosomes as drug carriers in drug-resistant treatment of gynecological tumors in order to to providing assistance in the clinical treatment of gynecological tumors. [ABSTRACT FROM AUTHOR]